The promotion of mitochondrial oxidative stress associated with the deletion/inhibition of NOX4 in hepatocytes diminished insulin signaling, whereas NOX4 deficiency in vivo promoted hepatic and systemic insulin resistance, a key driver of NAFLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.